SCHEMBL35211753

SCHEMBL35211753

COc1cc2c3n(nc2c(F)c1Br)CCN(C(=O)COC(C)=O)[C@@H]3C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35212287 1.00 — —
SCHEMBL35211711 1.00 — —
SCHEMBL35212609 0.89 EGFR (0.33) —
SCHEMBL35212559 0.89 EGFR (0.33) —
SCHEMBL35212633 0.89 EGFR (0.33) —
SCHEMBL35212552 0.81 TLR9 (0.34) —
SCHEMBL35211306 0.77 KMT2A (0.35) —
SCHEMBL35211418 0.76 CCR1 (0.32) —
SCHEMBL35211347 0.76 CCR1 (0.32) —
SCHEMBL35212023 0.76 CFD (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125383-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 — — US disclosed
Send feedback